HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsukasa Sasaki Selected Research

Cataplexy

12/2018A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.
1/2013Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsukasa Sasaki Research Topics

Disease

29Schizophrenia (Dementia Praecox)
11/2020 - 01/2002
12Autistic Disorder (Autism)
11/2018 - 01/2004
9Autism Spectrum Disorder
12/2021 - 03/2010
9Panic Disorder (Panic Attack)
01/2021 - 11/2002
7Mental Disorders (Mental Disorder)
12/2013 - 04/2002
6Anxiety Disorders (Anxiety Disorder)
04/2021 - 11/2002
5Narcolepsy
12/2018 - 01/2013
4Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
06/2005 - 11/2002
3Infections
05/2019 - 01/2004
3Neuroblastoma
05/2017 - 11/2005
3Bipolar Disorder (Manic Depressive Psychosis)
01/2007 - 07/2004
2Cataplexy
12/2018 - 01/2013
2Disorders of Excessive Somnolence (Hypersomnia)
12/2018 - 01/2013
2Neurodevelopmental Disorders
01/2015 - 01/2007
2Psychotic Disorders (Schizoaffective Disorder)
09/2013 - 08/2005
2Wounds and Injuries (Trauma)
04/2012 - 07/2003
2Mood Disorders (Mood Disorder)
05/2010 - 04/2002
2Poisoning
06/2005 - 11/2002
2Leukemia
06/2003 - 02/2003
1Bullous Pemphigoid (Pemphigoid)
05/2019
1Endometrial Neoplasms (Endometrial Cancer)
05/2017
1Adenocarcinoma of Lung
05/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
05/2017
1Glioma (Gliomas)
05/2017
1Kidney Neoplasms (Kidney Cancer)
05/2017
1Melanoma (Melanoma, Malignant)
05/2017
1Ovarian Neoplasms (Ovarian Cancer)
05/2017
1Testicular Neoplasms (Testicular Cancer)
05/2017
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2016
1Pain (Aches)
01/2013
1Sleep Wake Disorders
01/2013
1Gangrene
04/2012
1Osteomyelitis
04/2012
1Cellulitis
04/2012
1Abscess
04/2012
1Endometriosis
12/2010
1Depressive Disorder (Melancholia)
12/2010

Drug/Important Bio-Agent (IBA)

7Biological ProductsIBA
11/2018 - 11/2002
6HLA Antigens (Human Leukocyte Antigens)IBA
12/2018 - 01/2002
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 07/2004
5Oxytocin Receptors (Oxytocin Receptor)IBA
01/2017 - 03/2010
5Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2014 - 10/2006
5SarinIBA
01/2007 - 11/2002
3Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2021 - 05/2006
3HLA-DQB1 antigen (HLA DQB1)IBA
12/2018 - 01/2013
3HLA-DRB1 Chains (HLA DRB1)IBA
01/2016 - 05/2015
3Glutamic Acid (Glutamate)FDA Link
10/2015 - 05/2007
3Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
10/2015 - 12/2006
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
03/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2008
2ORALIT (ORS)IBA
05/2017 - 01/2017
2GTP-Binding Proteins (G-Protein)IBA
10/2016 - 06/2011
2Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2014 - 01/2009
2Biomarkers (Surrogate Marker)IBA
12/2013 - 07/2008
2Serotonin (5 Hydroxytryptamine)IBA
05/2010 - 03/2005
2Messenger RNA (mRNA)IBA
07/2008 - 03/2008
2Cholinesterases (Cholinesterase)IBA
06/2005 - 11/2002
2Hemoglobins (Hemoglobin)IBA
09/2003 - 07/2003
2HLA-A Antigens (HLA-A)IBA
08/2002 - 01/2002
1Histones (Histone)IBA
12/2021
1EnzymesIBA
12/2021
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2021
1BenzodiazepinesIBA
04/2021
1NucleotidesIBA
11/2020
1Betaine (C.B.B.)FDA Link
01/2020
1SteroidsIBA
05/2019
1Estrogen Receptor alphaIBA
11/2018
1glycine cleavage systemIBA
03/2018
1Oxytocin (Pitocin)FDA LinkGeneric
01/2017
1Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA
10/2016
1Purinergic Receptors (Receptors, Purine)IBA
10/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2016
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2016
1CC ChemokinesIBA
10/2015
1Antipsychotic Agents (Antipsychotics)IBA
02/2015
1NeuropeptidesIBA
05/2014
1OrexinsIBA
05/2014
1methionylmethionine (Met-Met)IBA
01/2014
1Methamphetamine (Desoxyn)FDA LinkGeneric
09/2013
1Indicators and Reagents (Reagents)IBA
01/2013
1Anti-Bacterial Agents (Antibiotics)IBA
04/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2012
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2011
1InterleukinsIBA
12/2010
1Protein Isoforms (Isoforms)IBA
05/2010
1CB2 Cannabinoid ReceptorIBA
05/2010
1CannabinoidsIBA
05/2010
1EndocannabinoidsIBA
05/2010
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
05/2010
1Dopamine D3 ReceptorsIBA
01/2010
1N-Methylaspartate (NMDA)IBA
04/2009
1Sigma-1 ReceptorIBA
04/2009
1Psychotropic Drugs (Psychoactive Drugs)IBA
04/2009
1Dopamine Receptors (Dopamine Receptor)IBA
04/2009
1Cell Adhesion MoleculesIBA
02/2009

Therapy/Procedure

2Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2003 - 02/2003
1Surgical Amputation (Amputations)
04/2012
1Debridement
04/2012
1Therapeutics
04/2012